“The Role of Intralesional Glucantime in Treating Cutaneous Leishmaniasis Lesions Complicated by Secondary Bacterial Infections: Research Article” (2025) Pak-Euro Journal of Medical and Life Sciences, 8(1), pp. 219–226. doi:10.31580/pjmls.v8i1.3238.